CORRECTION article

Front. Vet. Sci., 02 August 2023

Sec. Veterinary Surgery

Volume 10 - 2023 | https://doi.org/10.3389/fvets.2023.1252778

Corrigendum: Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis: a prospective, block-randomized, double-blinded, placebo-controlled clinical trial

  • 1. Division of Surgery, Faculty of Veterinary Medicine, Khon Kaen University, Khon Kaen, Thailand

  • 2. Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Khon Kaen University, Khon Kaen, Thailand

  • 3. Faculty of Veterinary Sciences, Mahasarakham University, Maha Sarakham, Thailand

  • 4. Translational Research in Pain Program, Comparative Pain Research and Education Centre, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, United States

  • 5. Center for Translational Pain Research, Department of Anesthesiology, Duke University, Durham, NC, United States

  • 6. Thurston Arthritis Center, UNC, Chapel Hill, NC, United States

Article metrics

View details

6

Citations

3,4k

Views

1k

Downloads

In the published article, there was an error in the Funding statement. The funding statement stated that the funder was VetzPetz Asia Company when it was actually Pharmalink International Ltd. The correct Funding statement appears below.

Statements

Funding

This work was funded by Pharmalink International Ltd., Central, Hong Kong and supported by the Faculty of Veterinary Medicine, Khon Kaen University. The authors declare that the funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

OA, marine-based fatty acid, non-steroidal anti-inflammatory drug (NSAID), gait analysis, PVF

Citation

Kampa N, Kaenkangploo D, Jitpean S, Srithunyarat T, Seesupa S, Hoisang S, Yongvanit K, Kamlangchai P, Tuchpramuk P and Lascelles BDX (2023) Corrigendum: Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis: a prospective, block-randomized, double-blinded, placebo-controlled clinical trial. Front. Vet. Sci. 10:1252778. doi: 10.3389/fvets.2023.1252778

Received

04 July 2023

Accepted

25 July 2023

Published

02 August 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

10 - 2023

Updates

Copyright

*Correspondence: B. Duncan X. Lascelles

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics